Login to Your Account



Earnings Roundup


Monday, April 22, 2013
• Cubist Pharmaceuticals Inc., of Lexington, Mass., reported first-quarter net revenues of $202 million for antibiotic Cubicin (daptomycin for injection), a 9 percent increase over the first quarter of 2012.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription